Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
Status:
RECRUITING
Trial end date:
2025-11-15
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine how Qlosi (pilocarpine HCL ophthalmic solution) 0.4%impacts the quality of life of participants with presbyopia by using a battery of validated and investigator-developed instruments
* Improvement in presbyopic symptoms as measured with the Near Activity Visual Questionnaire-Presbyopia (NAVQ-P) when using Qlosi at week 4 compared to baseline (continuous variable).
* Improvement in presbyopic symptoms as measured with the Visual Quality of Life with Time Survey (VisQualT) questionnaire when using Qlosi at week 4 compared to baseline.